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Summary.-The growth of s.c. Walker256 carcinoma was found to be independent of
secondary growths induced by i.v. injection. Tumour cells injected i.v. lodged mainly
in the lungs, with small clusters of cells in the lymph nodes. The rate of cellular
proliferation of these secondary growths of Walker carcinoma was significantly
higher than that observed in the s.c. tumour. In addition, host lung tissue was found
to inhibit the development of metastases, and it is postulated that the host tissue may
produce a diffusible inhibitor and thatdifferences inthe effectiveness ofthesehumoral
factors may account, in part, for locational differences in tumour growth patterns.
IT is generally recognised that one ofthe
most lethal aspects ofmalignant neoplasia
is the formation of metastases (Foulds,
1969). As a result, a great deal ofinforma-
tion has been presented on the mechanism
of invasion, lodgement and establishment
of metastases (Baserga, Kisieleski and
Halvorsen, 1960; Carr, Norris and Mc-
Ginty, 1975; Saidel, Liotta and Kleiner-
man, 1976). It has been suggested that
metastasis results from the selection of
tumour cells, and it may bethatthisselec-
tive lodgement gives rise to a clone of cells
which behave differently from those ofthe
primary tumour (Trope, 1975). Obviously,
any differences in behaviour between the
primary tumour and its metastases is
relevant to therapy. The Walker 256
carcinoma is widely used in pharma-
cological studies, but is rarely the model
for metastatic growth. It was, therefore,
the aim of the present work to quantify
cellular proliferation in the primary, solid
Walker tumour relative to metastases, as
well as to determine the influence of
lodgement site on the development of
metastases.
MATERIALS AND METHODS
Animals.-20-week-old male rats of an
inbred WAB substrain were used throughout
the present experiments. Walker 256 carci-
noma cells were obtained from 20-week-old
donor rats bearing the tumour in ascitic
form. The number oftumour cells present was
determined by counting representative sam-
ples of ascites, diluted with sterile, isotonic
saline, using a haemocytometer. 2-0x 104
cells were injected s.c. over the left femoral
vein and, simultaneously, i.v. into the right
femoral vein. The animals were killed by
cervical dislocation from 0 to 9 days after
tumour-cell administration.
Colchicine administration.-Pilot experi-
ments have shown that 0-2 mg of colchicine/
100 g body weight, administered 4 h prior to
death, was the most suitable regime for
halting proliferating Walker tumour cells at
metaphase. Therefore, this dose of colchicine
was administered at 11.00 h and the animals
killed at 15.00 h.
Histology.-Tumour and samples of host
lung, lymph nodes, spleen, liver, kidney and
thymus were fixed in Bouin's fluid for 24 h,
washed, dehydrated through graded alcohols
and vacuum-embedded in paraffin wax.
Sections were cut at 5 ,um and stained with
Mayer's haematoxylin.
Cell counts.-The total tumour-cell frag-
ments in 200 microscope fields (180 ,um diam.)
were counted, and the number of mitotic
figures scored. Only obvious tumour cells
were included and the necrotic areas of s.c.
tumours were avoided. Sectioning tissue
frequently results in fragmentation of theD. BELLAMY AND S. M. HINSULL
cells, thus the number of cell fragments
present in a series of sections will be greater
than the number of whole cells in the intact
tissue. Therefore, the cell fragments scored
were corrected to numbers of whole cells,




0 to 3 days, the growth of the s.c. tumour
was exponential up to 8 days (Fig. 1). The
primary tumour was lethal at about 10
days and the animals showed no signs of
spontaneous metastasis.
Tumour cells injected i.v. lodged main-
ly in the lungs. Forty-eight hours after





scattered under the pleura ofthe lungs. At
72 h, small clusters of cells were observed,
but excisable nodules were not found until
6 days. By 9 days only small areas of
normal lung tissue could be recognised,
interspersed in the tumour mass. The host
animals were moribund by this stage.
In the lymph nodes, single tumour cells
were found sparsely distributed in the
subcapsular sinus 3 days after injection.
This tumour cell subpopulation pro-
gressively invaded the lymphatic tissue,
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FIG. 1.-Growth curve of solid, subcutaneous
Walker 256 carcinoma from time of trans-
plantation until 9 days later, when death
occurred. (Results expressed as mean+s.e.
tumour weight ing.)
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FIG. 2.-The mitotic indices of the primary
Walker tumour *, lung metastases A, and
lymphnode metastases A, from the time of
transfer into a new host until the death of









rPROLIFERATION OF METASTASES IN RAT
small clusters of tumour cells were
present; macroscopically visible nodules
were not observed.
With the exception ofthe thymus, where
isolated tumour cells were occasionally
observed beneath the capsule, metastases
were not found in any other tissue, and
were notably absent from liver, kidney
and spleen.
Fig. 2 shows the overall 4h-accumulated
mitotic count ofthe s.c. solid tumour from
the time of growth initiation at 2 days
until death occurred at 9 days. As the
tumour became established in the host and
underwent the initial growth phase be-
tween 2 and 4 days, a 2-fold increase in
cellular proliferation was observed. There-
after, the 4h-accumulated MI remained
constant until the time of death. This
corresponded with the period when maxi-
mum growth rate was observed.
Insufficient clusters of tumour cells
were present in the lungs until 6 days, and
in the lymph nodes until 9 days after
injection, to warrant counting. At 6 days
the 4h-accumulated mitotic count in lung
metastases was significantly higher than
that observed in the solid s.c. tumour
(Fig. 2). A further increase in lung-tumour
cellular proliferation was observed at 8
days, but on the 9th day after injection
the 4h-accumulated MI fell dramatically.
The 4h-accumulated MI in lymph-node
metastases, at 9 days, was significantly
higher than that of either the primary
tumour or the lung metastases at this stage
(Fig. 2). However, the rate of cellular
proliferation was comparable inthelymph-
node metastases at 9 days and the lung
metastases at 8 days, when the peak
accumulated MI was observed.
When metastatic cells were counted in
the lungs, the microscope fields were cate-
gorised according to the presence of lung
tissue interspersed with tumour cells, the
peripheral 120um ofthe main tumour mass
or the central tumour mass.
A gradation of the 4h-accumulated MI
was observed across the metastatic nod-
ules (Fig. 3). The highest rate of cellular
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Fic. 3. The mitotic index of: A, Walker
tumour cells interspersed with host lung
tissue; B, tumour cells at the periphery ofa
solid tumour mass within the lung; and C,
tumour cells at the centre of the tumour
mass within lung. (Results expressed as
mean+s.e. ° mitosis).
tumour mass, with a significantly lower
rate of mitosis at the periphery of the
main tumour mass, and a further signifi-
cant decrease in tumour-cell mitosis in the
presence of lung tissue. These locational
differences in the accumulated mitotic
count were observed at all 3 sampling
times after tumour-cell injection. Un-
fortunately, the sparsity of tumour-cell
clusters made this kind of classification of
tumour-cell counts in the lymph nodes
impossible.
DISCUSSION
The present findings using the 4h-
accumulated mitotic count as an indicator
of cellular proliferation agree with the
c 1-
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earlier report of Bertalanffy and Lau
(1962) that, following the latent period, no
significant variation occurred in cellular
proliferation during growth of solid tum-
ours. The tumour grew at a steady rate
after adaptation to a new host.
The higher rate of cellular proliferation
in the lung and lymph-node metastases,
when compared with primary tumours of
either the same size or the same time after
cell injection, supports the evidence of
Kiseleva (1961) and that of Simpson-
Herren, Sanford and Holmquist (1974)
who showed that the cell cycle and S
phase were shorter in Lewis lung carcin-
oma metastases than in the primary
tumour. These findings are consistent with
the greater drug sensitivity of lung
metastases reported by Trope (1975).
It may be suggested that this difference
in cellular proliferation between metasta-
ses and primary tumour arises from
selection of cells during or after implanta-
tion, resulting in a biochemically different
phenotype in the metastases. This conten-
tion has some support from the work of
Trope (1975) who demonstrated increased
drug sensitivity in subcutaneous tumours
derived from successive passages of the
tumour as metastases.
Alternatively, it could be postulated
that local factors in the host tissue specifi-
ally influence tumour proliferation. This
may take the form of a more adequate
blood supply and better nutrition in the
metastases than in the primary tumour.
The fact that necrotic areas were never
observed in metastatic nodules supports
this idea.
Our findings of a higher rate of cellular
proliferation in the central mass of the
metastases than in the peripheral areas
may also be explained by regional differ-
ences in blood supply to the metastases.
It may be that the established core of the
tumour nodules is particularly well vascu-
larised, compared with the periphery of
the nodule. This rich vascularization may
result in a higher rate of cellular prolifera-
tion near the capillaries (Tannock, 1970)
as well as the removal oftoxic metabolites,
which may be one ofthe causes ofnecrosis
and inhibition of cell division (Broyn,
1975b).
However, there is increasing evidence of
humoral factors, emanating from the host
tissue, which influence tumour growth
(Billingham and Silvers, 1971; Broyn,
1975a; Lowenstein and Penn, 1967; Van
Scott and Reinertson, 1961). Thus, the
possibility that host lung tissue exerts
some inhibitory influence on the develop-
ment of metastases cannot be ignored. If
this is the case, the gradation of this
influence into the solid tumour mass
indicates that this is not a cell-contact
phenomenon, but rather supports the
theory of diffusible humoral factor. In
addition it may be tentatively suggested
that differences in the effectiveness ofhost
inhibitors may be involved in different
site patterns of tumour growth.
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